Skip to main content
Erschienen in:

12.08.2024 | Clinical Investigation

Newly Designed, Self-Expanding Large-Bore Nitinol Stents for Symptomatic Central Venous Stenosis: Technical and Long-Term Clinical Outcome

verfasst von: Geert Maleux, Eveline Claus, Annouschka Laenen, Pieter-Jan Buyck, Kathleen Claes, Lawrence Bonne, Kris Nackaerts, Christophe Dooms

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 9/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively analyze the technical and long-term clinical outcome of angioplasty and stenting using the Venovo™ venous stent for the treatment of malignant and benign superior vena cava (SVC) occlusive disease.

Materials and Methods

Consecutive patients treated with the Venovo™ venous stent for SVC occlusive disease were included. SVC obstruction symptoms were classified according to the Kishi score. The Wilcoxon signed-rank test was used for testing significance of changes. Technical success, defined as correct placement of the stent, completely covering and re-expanding the obstruction, between groups was tested using the Fisher exact test. Overall survival was calculated using the Kaplan–Meier method.

Results

Fifty-five patients underwent stent insertion for symptomatic benign (n = 13; 24%) or malignant (n = 42; 76%) SVC occlusive disease. A significant drop in Kishi score, mean 3.91 before versus mean 1.02 after the procedure (P < 0.0001), was observed. In one patient (1.8%), an additional balloon-expandable stent was needed to manage incomplete expansion of the nitinol stent. In one patient, a procedure-related lung embolic complication was noted. Early thrombotic occlusion of the stent occurred in one patient. Late symptomatic restenosis occurred in 3 patients. Overall primary stent patency and primary-assisted stent patency were 86% (95% CI 66–95) and 97% (95% CI 83–100) at 1-year follow-up and 98% (95% CI 87–100), 98% (87–100) at 2-year follow-up, respectively.

Conclusion

In this retrospective analysis, angioplasty and stent placement using the Venovo™ venous stent is safe and clinically effective for the treatment of both benign and malignant SVC occlusive disease. Reintervention for symptomatic restenosis is rare.

Graphical Abstract

Literatur
1.
Zurück zum Zitat Azizi A, Shafi I, Rosenfield K, Schainfeld R, Sista A, Bashir R. Superior vena cava syndrome. J Am Coll Cardiol Intv. 2020;13:2896–910.CrossRef Azizi A, Shafi I, Rosenfield K, Schainfeld R, Sista A, Bashir R. Superior vena cava syndrome. J Am Coll Cardiol Intv. 2020;13:2896–910.CrossRef
2.
Zurück zum Zitat Sonavane S, Milner D, Singh S, Shahir K, Chaturvedi A. Comprehensive imaging review of the superior vena cava. Radiographics. 2015;35:1873–92.CrossRefPubMed Sonavane S, Milner D, Singh S, Shahir K, Chaturvedi A. Comprehensive imaging review of the superior vena cava. Radiographics. 2015;35:1873–92.CrossRefPubMed
3.
Zurück zum Zitat Jalaie H, Gombert A, Grommes J, Schleimer K, Kurstjens R, de Graaf R, Wittens C, Razavi M, Barbati M. Outcome of stenting in central venous obstruction of benign etiology. VASA. 2021;50:45–51.CrossRefPubMed Jalaie H, Gombert A, Grommes J, Schleimer K, Kurstjens R, de Graaf R, Wittens C, Razavi M, Barbati M. Outcome of stenting in central venous obstruction of benign etiology. VASA. 2021;50:45–51.CrossRefPubMed
4.
Zurück zum Zitat Gabriels J, Chang D, Maytin M, Tadros T, John R, Sobieszczyk P, Eisenhauer A, Epstein L. Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2021;18:392–8.CrossRefPubMed Gabriels J, Chang D, Maytin M, Tadros T, John R, Sobieszczyk P, Eisenhauer A, Epstein L. Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2021;18:392–8.CrossRefPubMed
5.
Zurück zum Zitat Sfyroeras G, Antonopoulos C, Mantas G, Moulakakis K, Kakisis J, Brountzos E, Lattimer C, Geroulakos G. A review of open and endovascular treatment of superior vena cava syndrome of benign aetiology. Eur J Vasc Endovasc Surg. 2017;53:238–54.CrossRefPubMed Sfyroeras G, Antonopoulos C, Mantas G, Moulakakis K, Kakisis J, Brountzos E, Lattimer C, Geroulakos G. A review of open and endovascular treatment of superior vena cava syndrome of benign aetiology. Eur J Vasc Endovasc Surg. 2017;53:238–54.CrossRefPubMed
6.
Zurück zum Zitat Dabir D, Feisst A, Thomas D, Luetkens J, Meyer C, Kardulovic A, Menne M, Steinseifer U, Schild H, Kuetting D. Physical properties of venous stents: an experimental comparison. Cardiovasc Intervent Radiol. 2018;41:942–50.CrossRefPubMed Dabir D, Feisst A, Thomas D, Luetkens J, Meyer C, Kardulovic A, Menne M, Steinseifer U, Schild H, Kuetting D. Physical properties of venous stents: an experimental comparison. Cardiovasc Intervent Radiol. 2018;41:942–50.CrossRefPubMed
7.
Zurück zum Zitat Dake M, O’Sullivan G, Shammas N, Lichtenberg M, Mwipatayi B, Settlage R. Three year results from the Venovo venous stent study for the treatment of iliac and femoral vein obstruction. Cardiovasc Intervent Radiol. 2021;44:1918–29.CrossRefPubMedPubMedCentral Dake M, O’Sullivan G, Shammas N, Lichtenberg M, Mwipatayi B, Settlage R. Three year results from the Venovo venous stent study for the treatment of iliac and femoral vein obstruction. Cardiovasc Intervent Radiol. 2021;44:1918–29.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kishi K, Sonomura T, Mitsuzane K, Nishida N, Yang R, Sato M, Yamada R, Shirai S, Kobayashi H. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology. 1993;189:531–5.CrossRefPubMed Kishi K, Sonomura T, Mitsuzane K, Nishida N, Yang R, Sato M, Yamada R, Shirai S, Kobayashi H. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology. 1993;189:531–5.CrossRefPubMed
9.
Zurück zum Zitat Dinkel H, Mettke B, Schmid F, Baumgartner I, Triller J, Do D. Endovascular treatment of malignant superior vena cava syndrome: Is bilateral Wallstent placement superior to unilateral placement? J Endovasc Ther. 2003;10:788–97.CrossRefPubMed Dinkel H, Mettke B, Schmid F, Baumgartner I, Triller J, Do D. Endovascular treatment of malignant superior vena cava syndrome: Is bilateral Wallstent placement superior to unilateral placement? J Endovasc Ther. 2003;10:788–97.CrossRefPubMed
10.
Zurück zum Zitat Haddad M, Simmons B, McPhail I, Kalra M, Neisen M, Johnson M, Stockland A, Andrews J, Misra S, Bjarnason H. Comparison of covered versus uncovered stents for benign superior vena cava (SVC) obstruction. Cardiovasc Intervent Radiol. 2018;41:712–7.CrossRefPubMedPubMedCentral Haddad M, Simmons B, McPhail I, Kalra M, Neisen M, Johnson M, Stockland A, Andrews J, Misra S, Bjarnason H. Comparison of covered versus uncovered stents for benign superior vena cava (SVC) obstruction. Cardiovasc Intervent Radiol. 2018;41:712–7.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Fagedet D, Thony F, Timsit J, Rodiere M, Monnin-Bares V, Ferretti G, Vesin A, Moro-Sibilot D. Endovascular treatment of malignant superor vena cava syndrome: Results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol. 2013;36:140–9.CrossRefPubMed Fagedet D, Thony F, Timsit J, Rodiere M, Monnin-Bares V, Ferretti G, Vesin A, Moro-Sibilot D. Endovascular treatment of malignant superor vena cava syndrome: Results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol. 2013;36:140–9.CrossRefPubMed
12.
Zurück zum Zitat Matthaiou N, Galanakis N, Kehagias E, Kontopodis N, Charalambous S, Kholcheva N, Tsetis K, Mavroudis D, Tsetis D. Endovascular treatment of malignant superior vena cava syndrome through upper limb access: a comparison between venous-dedicated and conventional stents. J Vasc Intervent Radiol. 2020;31:2066–72.CrossRef Matthaiou N, Galanakis N, Kehagias E, Kontopodis N, Charalambous S, Kholcheva N, Tsetis K, Mavroudis D, Tsetis D. Endovascular treatment of malignant superior vena cava syndrome through upper limb access: a comparison between venous-dedicated and conventional stents. J Vasc Intervent Radiol. 2020;31:2066–72.CrossRef
13.
Zurück zum Zitat Maleux G, Gillardin P, Fieuws S, Heye S, Vaninbroukx J, Nackaerts K. Large-bore nitinol stents for malignant vena cava superior syndrome: factors influencing outcome. Am J Roentgenol. 2013;201:667–74.CrossRef Maleux G, Gillardin P, Fieuws S, Heye S, Vaninbroukx J, Nackaerts K. Large-bore nitinol stents for malignant vena cava superior syndrome: factors influencing outcome. Am J Roentgenol. 2013;201:667–74.CrossRef
14.
Zurück zum Zitat Breault S, Doenz F, Jouannic A, Qanadli S. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes: long-term follow-up. Eur Radiol. 2017;27:97–104.CrossRefPubMed Breault S, Doenz F, Jouannic A, Qanadli S. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes: long-term follow-up. Eur Radiol. 2017;27:97–104.CrossRefPubMed
15.
Zurück zum Zitat Bundy J, Shin D, Meissner M, Monroe E, Chick J. Maldeployment of the Venovo stent: a series of 2 documented instances. J Vasc Intervent Radiol. 2021;32:781–2.CrossRef Bundy J, Shin D, Meissner M, Monroe E, Chick J. Maldeployment of the Venovo stent: a series of 2 documented instances. J Vasc Intervent Radiol. 2021;32:781–2.CrossRef
16.
Zurück zum Zitat Massara M, De Caridi G, Alberti A, Volpe P, Spinelli F. Symptomatic superior vena cava syndrome in hemodialysis patients: mid-term results of primary stenting. Semin Vasc Surg. 2016;29:186–91.CrossRefPubMed Massara M, De Caridi G, Alberti A, Volpe P, Spinelli F. Symptomatic superior vena cava syndrome in hemodialysis patients: mid-term results of primary stenting. Semin Vasc Surg. 2016;29:186–91.CrossRefPubMed
Metadaten
Titel
Newly Designed, Self-Expanding Large-Bore Nitinol Stents for Symptomatic Central Venous Stenosis: Technical and Long-Term Clinical Outcome
verfasst von
Geert Maleux
Eveline Claus
Annouschka Laenen
Pieter-Jan Buyck
Kathleen Claes
Lawrence Bonne
Kris Nackaerts
Christophe Dooms
Publikationsdatum
12.08.2024
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 9/2024
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-024-03820-y

Neu im Fachgebiet Radiologie

Röntgen-Thorax oder LDCT fürs Lungenscreening nach HNSCC?

Personen, die an einem Plattenepithelkarzinom im Kopf-Hals-Bereich erkrankt sind, haben ein erhöhtes Risiko für Metastasen oder zweite Primärmalignome der Lunge. Eine Studie hat untersucht, wie die radiologische Überwachung aussehen sollte.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Brustdichte nicht mit Multivitaminpräparat-Einnahme assoziiert

Der regelmäßige Gebrauch von Nahrungsergänzungsmitteln scheint nicht die mammografische Brustdichte zu erhöhen. In einer US-amerikanischen Studie jedenfalls ließ sich ein derartiger Zusammenhang nicht bestätigen.

Erhöhte Suizidrate unter US-Ärztinnen

Während der Arztberuf Männer eher vor Suizid schützt, erhöht er das Risiko bei Frauen – zumindest in den USA: Die Suizidinzidenz unter Ärztinnen ist um die Hälfte höher als unter Frauen mit anderen Berufen. Männliche Ärzte töten sich dennoch wesentlich häufiger selbst als weibliche.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.